Comparison of the in vitro DNA-damaging potential of the two anticancer drugs idarubicin and mitomycin C in the presence of NADPH-cytochrome P450 reductase
9th European Meeting of the International-Society-for-the-Study-of-Xenobiotics (ISSX), Manchester, United Kingdom, 4 - 07 June 2006, vol.38, pp.185-186
